切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2015, Vol. 03 ›› Issue (04) : 271 -273. doi: 10.3877/cma.j.issn.2095-655X.2015.04.013

所属专题: 文献

临床研究

17β-羟基类固醇脱氢酶10病的临床诊断并文献复习
盛志强1, 满宜刚1,()   
  1. 1. 272011 济宁市第一人民医院儿童康复科
  • 收稿日期:2015-06-17 出版日期:2015-11-26
  • 通信作者: 满宜刚
  • 基金资助:
    山东省中医药项目(2013-309); 济宁市科技局项目(2013jnwk127)

Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease

Zhiqiang Sheng1, Yigang Man1,()   

  1. 1. Department of Pediatric Rehabilitation, The First People′s Hospital of Jining, Jining 272011, China
  • Received:2015-06-17 Published:2015-11-26
  • Corresponding author: Yigang Man
  • About author:
    Corresponding author: Man Yigang, Email:
引用本文:

盛志强, 满宜刚. 17β-羟基类固醇脱氢酶10病的临床诊断并文献复习[J/OL]. 中华诊断学电子杂志, 2015, 03(04): 271-273.

Zhiqiang Sheng, Yigang Man. Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2015, 03(04): 271-273.

目的

探讨17β-羟基类固醇脱氢酶10(HSD10)病的临床诊断学特征。

方法

回顾性分析济宁市第一人民医院儿童康复科收治的1例HSD10病患儿临床资料,并复习文献。

结果

患儿临床表现为精神发育倒退、抽搐、水平性眼球震颤。颅脑磁共振、动态脑电图和血酰基肉碱分析、尿有机酸分析均未见明显异常,心肌酶示谷草转氨酶79.8 U/L、肌酸激酶221 U/L、肌酸激酶同工酶43.5 U/L、乳酸脱氢酶356 U/L、羟丁酸脱氢酶339 U/L;神经心理发育评估示中度智力低下,基因检测示患儿HSD17B10基因在外显子4发生c.388C>T(p.R130C)改变,确诊为HSD10病。

结论

HSD10病主要损害神经系统,表现为明显的精神运动发育迟滞;确诊依赖于基因检测,表现为HSD17B10基因突变。

Objective

To explore the diagnostic features of 17β-Hydroxysteroid dehydrogenase 10 disease(HSD10 disease).

Methods

The clinical data of a 7-months-old infantile who was diagnosed in the First People′s Hospital of Jining was retrospectively analyzed, and relevant literatures were reviewed.

Results

The boy was mainly presented with neurodegeneration, convulsion, and horizontal nystagmus.The cerebral magnetic resonance imaging and the ambulatory electroencephalogram were negative.The blood acylcarnitine and urinary organic acid analysis were normal.The concentrations of serum myocardial enzymes increased, including glutamic oxalocetic transaminase (79.8U/L), creatine kinase (221U/L), creatine kinase isoenzyme MB (43.5U/L), lactate dehydrogenase (356U/L), hydroxybutyric dehydrogenase (339U/L). The neurological development was moderate mental retardation.The diagnosis was confirmed by molecular genetic study of the gene HSD17B10.The patient was hemizygous for the previously described mutation p. R130C (c.388C>T).

Conclusions

HSD10 disease mainly damages the nervous system.Affected patients show a progressive neurodegenerative disease course.Confirmation of the diagnosis is based on the identification of a disease-causing mutation in the HSD17B10 gene.

[1]
Zschocke, J.HSD10 disease:clinical consequences of mutations in the HSD17B10 gene[J]. J Inherited Metab Dis, 2012, 35(1): 81-89.
[2]
Zschocke J,Ruiter JPN,Brand J, et al.Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deciency:a novel inborn error of branched-chain fatty acid and isoleucine catabolism[J]. Pediatr Res, 2000, 48(6): 852-855.
[3]
Ensenauer R,Niederhoff H,Ruiter JP, et al.Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. Ann Neurol, 2002, 51(5): 656-659.
[4]
Olpin SE,Pollitt RJ,McMenamin J, et al.2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man[J]. J Inherit Metab Dis, 2002, 25(6): 477-482.
[5]
Sutton VR,O’Brien WE,Clark GD, et al.3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. J Inherit Metab Dis, 2003, 26(1): 69-71.
[6]
Sass JO,Forstner R,Sperl W. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency:impaired catabolism of isoleucine presenting as neurodegenerative disease[J]. Brain Dev, 2004, 26(1): 12-14.
[7]
Poll-The BT,Wanders RJ,Ruiter JP, et al.Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases[J]. Mol Genet Metab, 2004, 81(4): 295-299.
[8]
Perez-Cerda C,Garcia-Villoria J,Ofman R, et al.2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency:an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease[J]. Pediatr Res, 2005, 58(3): 488-491.
[9]
Cazorla MR,Verdu A,Perez-Cerda C, et al.Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Pediatr Neurol, 2007, 36(4): 264-267.
[10]
Lenski C,Kooy RF,Reyniers E, et al.The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior[J]. Am J Hum Genet, 2007, 80(2): 372-377.
[11]
Garcia-Villoria J,Navarro-Sastre A,Fons C, et al.Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoAdehydrogenase(MHBD) deficiency:difficulties in the diagnosis[J]. Clin Biochem, 2009, 42(1-2): 27-33.
[12]
Rauschenberger K,Schöler K,Sass JO, et al.A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival[J]. EMBO Mol Med, 2010, 2(2): 51-62.
[13]
Seaver LH,He XY,Abe K, et al.A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability[J]. PLoS One, 2011, 6(11), e27348.
[14]
舒剑波,张玉琴,姜淑贞, 等.2甲基3羟基丁酰辅酶A脱氢酶缺陷症一家系基因突变分析[J]. 中华儿科杂志, 2013, 51(10): 783-786.
[15]
Fukao T,Akiba K,Goto M , et al.The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation.Journal of Human Genetics[J]. J Hum Genet, 2014, 59(9): 521-528.
[16]
满宜刚,盛志强. 婴儿痉挛征患儿智能结构变化对综合康复训练效果的判断价值[J/CD]. 中华诊断学电子杂志, 2014, 2(4): 298-300.
[17]
Korman SH,Yang SY.HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Mol Genet Metab, 2007, 91(1): 115.
[18]
He XY,Merz G,Yang YZ, et al.Characterization and localization of human type10 17beta hydroxysteroid dehydrogenase[J]. Eur J Biochem, 2001, 268(18): 4899-4907.
[19]
Yang SY,He XY,Isaacs C, et al.Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders[J]. J Steroid Biochem Mol Biol, 2014, 143: 460-472.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[3] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[6] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[7] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[8] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[13] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 朱旦华, 卢放根. 以腹水为主要特征的Castleman病16例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 462-473.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?